CHICAGO--(BUSINESS WIRE)--Doctors are finding that contrast enhanced ultrasound (CEUS) is so effective in imaging kidney masses in patients with polycystic kidney disease that “they go right to CEUS ...

CHICAGO--(BUSINESS WIRE)--Ultrasound contrast agents show promise for detecting and evaluating uterine disorders and prostate cancers, scientists reported today at the annual Advances in Contrast ...

A new study shows that contrast enhanced ultrasound (CEUS) techniques offer an encouraging option for noninvasively detecting pancreatic cancer in its early stages, when treatment may help save lives, ...

A new contrast agent could allow real-time monitoring of pH changes in the body using an ultrasound scanner (ACS Sens. 2020, DOI: 10.1021/acssensors.0c00245). This expansion of the use of ultrasound ...

Contrast-enhanced ultrasound (CEUS) has increasingly emerged as a pivotal imaging modality in the diagnosis and management of abdominal trauma. By utilising microbubble contrast agents, CEUS enhances ...

One of the reasons cardiovascular disease kills 610,000 Americans each year is that it’s hard to see it coming before it’s too late. By the time someone is experiencing chest pain, irreversible damage ...

Announcing a new article publication for BIO Integration journal. Hepatic perivascular epithelioid cell tumor (PEComa) is a rare tumor with malignant potential that is frequently misdiagnosed as ...

The International Contrast Ultrasound Society supports the label change of GE Healthcare’s ultrasound contrast agent Optison, according to a news release. Optison is used in contrast-enhanced ...